Supreme Court Seeks Response on Mandatory Cancer Notification: A Potential Watershed Moment for India’s Oncology Care

Spread the Message

Read Time:5 Minute, 35 Second

NEW DELHI — In a move that could fundamentally reshape how India tracks and treats its growing cancer burden, the Supreme Court of India has issued a notice to the Central Government and all state governments, seeking their response on a Public Interest Litigation (PIL) that demands cancer be declared a “notifiable disease” nationwide.

The bench, comprising Chief Justice of India Surya Kant and Justices Joymalya Bagchi and Vipul M. Pancholi, responded on Friday to a plea filed by Dr. Anurag Srivastava, the former head of the Department of Surgical Disciplines at the All India Institute of Medical Sciences (AIIMS), New Delhi. The petition argues that the lack of a mandatory notification system has created a “data black hole,” leaving nearly 90% of the Indian population outside the coverage of systematic cancer surveillance.

The “Data Black Hole”: Why Notification Matters

Currently, cancer is not a nationally notifiable disease in India, unlike Tuberculosis (TB) or COVID-19. This means healthcare providers are not legally legally obligated to report every diagnosed case to a central authority. Consequently, India relies on the National Cancer Registry Programme (NCRP), run by the Indian Council of Medical Research (ICMR).

While the NCRP is a vital tool, its reach is limited. According to the petition, the registry covers only about 10% of India’s population, with rural coverage plummeting to as low as 1%.

“Because the continued non-notification of cancer, despite its alarming and escalating burden in India, amounts to a grave abdication of the State’s constitutional duty,” the plea stated, arguing that this data deficit leads to “policy paralysis.” Without accurate numbers, the government cannot effectively allocate resources, plan screening camps, or identify regional cancer clusters caused by environmental factors like groundwater contamination or industrial pollution.

The Precedent: From TB to Snakebites

The debate over “notifiable status” often centers on the definition of the term. Historically, notification was reserved for infectious diseases (like cholera or plague) to prevent immediate community spread. The Union Health Ministry has previously resisted making cancer notifiable, citing its non-communicable nature.

However, the landscape of public health surveillance is shifting. In 2024, the government declared snakebite—a non-communicable condition—a notifiable disease to better manage antivenom stockpiles and reduce mortality. The PIL argues that if snakebites warrant mandatory reporting, the country’s “cancer epidemic” demands it even more urgently.

Comparisons are also being drawn to India’s success with Tuberculosis. The mandatory notification of TB and the implementation of the Ni-kshay digital portal revolutionized TB care, allowing for real-time tracking of patients and ensuring adherence to treatment protocols. The petitioner envisions a similar “unified, real-time digital cancer registry,” potentially modeled after the CoWIN platform used during the pandemic.

A Patchwork of Policies

The current system creates what the petitioner describes as a “legal vacuum.” While there is no national mandate, approximately 17 states—including Punjab, West Bengal, Karnataka, and recently Himachal Pradesh—have independently declared cancer a notifiable disease through administrative orders.

This fragmentation results in stark disparities. A patient in a state with mandatory reporting might benefit from state-sponsored follow-ups and better-funded local oncology centers, while a patient in a neighboring state remains a statistic lost in hospital files. The PIL seeks to erase these geographic inequalities by enforcing a uniform national standard.

Statistical Context: The Silent Epidemic

The urgency of the court’s intervention is underscored by grim statistics.

Rising Incidence: According to ICMR-NCDIR estimates, India reported over 14.6 lakh new cancer cases in 2022.
Projected Growth: This number is projected to rise by 12.8% by 2025.
Lifetime Risk: One in nine Indians will develop cancer during their lifetime.
Late Diagnosis: Due to poor screening mechanisms, a significant majority of patients present at Stages III or IV, where curative treatment is difficult and financial toxicity is highest.

Combating Misinformation

A less discussed but critical aspect of the PIL is the regulation of unscientific treatments. The petition highlights the “growing menace” of unverified claims, specifically citing the promotion of Gomutra (cow urine) as a cancer cure. It points to an RTI response from the National Institute of Ayurveda which confirmed that no scientific research establishes cow urine as an effective cancer therapy.

By mandating notification and centralizing data, the government could better regulate treatment pathways, ensuring patients are funneled into evidence-based care systems rather than falling prey to quackery that delays life-saving medical intervention.

Expert Perspectives

While the government formulates its response, the medical community has largely rallied behind the call for better data.

Dr. R. Singh, a researcher advocating for cancer notification, noted in a recent commentary that “Robust record-keeping would allow real-time epidemiological analysis and highlight those areas where priority could be given to both prevent and treat cancer.”

Similarly, experts from the Tata Memorial Centre have previously suggested that if the government is hesitant to use the term “notifiable” due to its infectious disease connotations, cancer could be classified as a “documentable disease” to achieve the same goal of mandatory reporting without semantic hurdles.

Implications for the Public

For the average citizen, this legal development could have tangible impacts:

Better Access: Accurate local data could force governments to build cancer care centers in under-served districts where high case loads are identified.
Early Detection: A national registry could facilitate automated reminders for screenings (mammograms, pap smears) based on age and risk factors.
Standardized Care: Mandatory reporting could help standardize treatment protocols across private and public hospitals, reducing the variance in care quality.

Challenges Ahead

Implementing a national registry is not without challenges. Privacy advocates may raise concerns about the confidentiality of sensitive health data. Furthermore, an already overburdened healthcare workforce may view mandatory reporting as an additional bureaucratic hurdle. Any successful policy will need to balance the need for data with patient privacy and ease of compliance for doctors.

Conclusion

The Supreme Court’s notice is the first step in a long legal and administrative process. However, it signals a recognition that in the fight against cancer, data is as critical as chemotherapy. As India grapples with being dubbed the “Cancer Capital of the World,” the transition from fragmented silence to mandatory notification could be the turning point in the nation’s battle for health security.

Medical Disclaimer:

This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References: